Hydrosalpinx and Fertility: A Complete Guide for Indian Women

Hydrosalpinx (plural: hydrosalpinges) is a condition in which a fallopian tube becomes blocked at its distal end (the fimbrial end, nearest the ovary) and fills with clear, straw-coloured fluid. The term comes from the Greek: hydro (water) and salpinx (tube).

In a healthy fallopian tube, the fimbrial end is open and lined with delicate finger-like projections (fimbriae) that sweep across the ovarian surface to capture the released egg after ovulation. When infection, inflammation, or other damage destroys the fimbriae and seals the tube shut, fluid secreted by the tubal lining has no exit. Over time, the tube distends and balloons outward, sometimes reaching several centimetres in diameter.

The result is a non-functioning tube that:

• Cannot capture eggs or transport sperm
• Accumulates inflammatory fluid that is embryotoxic
• May leak this fluid into the uterine cavity, impairing implantation
• Can be unilateral (one tube) or bilateral (both tubes)

How Hydrosalpinx Differs from a Simple Tubal Blockage

Not all blocked fallopian tubes are hydrosalpinges. A tube can be blocked at the proximal end (near the uterus) by a mucus plug, spasm, or scarring without accumulating fluid. A hydrosalpinx specifically refers to a distal blockage with fluid accumulation. This distinction matters because:

• Simple tubal blockage: IVF effectively bypasses it. No additional intervention needed.
• Hydrosalpinx: IVF alone is insufficient. The fluid actively reduces implantation. Treatment of the hydrosalpinx before IVF is strongly recommended by all major fertility guidelines.

Prevalence

Hydrosalpinx is found in approximately:

• 10-30% of women with tubal factor infertility undergoing IVF
• 30% of all women with a history of pelvic inflammatory disease will develop some degree of tubal damage, and a proportion of these will progress to hydrosalpinx
• In Indian fertility centres, the prevalence may be higher due to the significant burden of genital tuberculosis (TB), which causes severe tubal destruction

A study from a large Indian IVF centre reported that hydrosalpinx was identified in approximately 15-20% of women presenting with tubal factor infertility, with genital TB as the underlying cause in a substantial proportion of cases.

Hydrosalpinx develops when infection, inflammation, or surgical trauma destroys the fimbrial end of the fallopian tube, causing it to seal shut and accumulate fluid. The most common causes include:

Pelvic Inflammatory Disease (PID) and Sexually Transmitted Infections

PID caused by Chlamydia trachomatis and Neisseria gonorrhoeae is the most common cause of hydrosalpinx worldwide. The ascending infection inflames the tubal mucosa (salpingitis), destroys the delicate fimbriae, and triggers adhesion formation that seals the distal end.

Chlamydia is particularly insidious because:

• Up to 70% of chlamydial infections in women are asymptomatic
• A single episode of chlamydial PID causes tubal damage in 12% of cases
• Repeated infections dramatically increase the risk: 23% after two episodes, 54% after three
• Many women discover the tubal damage years or decades after the original infection

Genital Tuberculosis -- A Major Cause in India

Genital TB is a critically important and often underappreciated cause of hydrosalpinx in India. Key facts:

• India accounts for approximately 27% of the world's TB burden
• Genital TB is found in approximately 18-19% of infertile women in India
• The fallopian tubes are affected in 90-100% of genital TB cases
• TB reaches the tubes via haematogenous spread (through the bloodstream) from a primary pulmonary focus that may have occurred years earlier
• TB causes granulomatous inflammation, caseous necrosis, and fibrosis that destroys the tubal architecture
• TB-related tubal damage is typically bilateral, extensive, and irreversible
• The resulting hydrosalpinges tend to be large and thick-walled

Endometriosis

Severe endometriosis (Stage III-IV) can cause chronic inflammation, adhesion formation, and fibrosis around the fallopian tubes. The fimbrial end may become buried under adhesions and sealed, leading to hydrosalpinx formation. Endometriosis-related hydrosalpinx is often associated with dense pelvic adhesions that make surgical treatment more challenging.

Prior Pelvic or Tubal Surgery

Previous surgery on or near the fallopian tubes -- including salpingotomy for ectopic pregnancy, tubal ligation reversal, fimbrioplasty, or ovarian surgery -- can trigger adhesion formation and subsequent hydrosalpinx development. Post-surgical hydrosalpinx may develop months or years after the initial procedure.

Ruptured Appendicitis

A ruptured appendix causes peritonitis (pelvic infection) that can damage the right fallopian tube due to anatomical proximity, occasionally resulting in right-sided hydrosalpinx.

Other Causes

• Previous ectopic pregnancy: Both the ectopic itself and its treatment can damage the tube
• Pelvic irradiation: Rare, but radiation therapy for pelvic cancers can cause tubal fibrosis

One of the most challenging aspects of hydrosalpinx is that it is frequently asymptomatic. Many women have no symptoms at all and discover the condition only during an infertility workup. When symptoms do occur, they may include:

Common Symptoms

• Infertility: Often the only presenting complaint. Couples who have tried to conceive for 12 months (or 6 months if the woman is over 35) without success
• Chronic pelvic pain: Dull, persistent lower abdominal discomfort, particularly on the affected side. Pain may be worse before or during menstruation
• Intermittent watery vaginal discharge: As the hydrosalpinx fluid periodically drains through the tubal lumen into the uterus and out through the cervix. This is a relatively characteristic symptom when present
• Pelvic pressure or fullness: With large hydrosalpinges, a sensation of pressure in the lower pelvis
• Recurrent pelvic pain episodes: May represent intermittent partial drainage and re-accumulation of fluid

When Hydrosalpinx is an Incidental Finding

In many cases, hydrosalpinx is discovered incidentally during:

• HSG (hysterosalpingography) performed as part of a routine infertility workup
• Transvaginal ultrasound showing a tubular fluid-filled structure adjacent to the ovary
• Diagnostic laparoscopy for another indication
• Imaging for unrelated pelvic complaints

Hydrosalpinx impairs fertility through multiple mechanisms. Crucially, unlike a simple tubal blockage, hydrosalpinx actively undermines IVF outcomes -- making it one of the few conditions where IVF alone is not sufficient.

1. Preventing Natural Conception

The sealed, fluid-filled tube cannot perform any of its normal functions:

• Fimbriae are destroyed, so the tube cannot capture the egg
• Sperm cannot traverse the blocked tube to reach the egg
• Even if fertilisation were somehow to occur, the embryo cannot travel through the distended, dysfunctional tube to the uterus

With bilateral hydrosalpinx, natural conception is essentially impossible. With unilateral hydrosalpinx, the other tube may function, but pregnancy chances are still significantly reduced -- not only because of reduced tubal capacity, but because of the toxic fluid effect described below.

2. The Toxic Fluid Theory: Embryotoxicity

This is the most clinically important mechanism. The fluid that accumulates in a hydrosalpinx contains:

• Inflammatory cytokines (interleukins, tumour necrosis factor)
• Oxidative stress mediators
• Endotoxins and bacterial debris (from the original infection)
• Altered growth factors that impair embryo development

This fluid can leak retrogradely through the tubal lumen into the uterine cavity, creating an environment that is directly toxic to embryos. Multiple studies have demonstrated that hydrosalpinx fluid:

• Impairs embryo development in vitro
• Reduces endometrial receptivity
• Alters endometrial gene expression important for implantation
• Mechanically flushes embryos from the uterine cavity (the "washout" effect)

3. Impact on IVF Outcomes

The clinical consequence is dramatic. In women with untreated hydrosalpinx undergoing IVF:

• Implantation rates are reduced by approximately 50% compared to women with tubal factor infertility without hydrosalpinx
• Clinical pregnancy rates are roughly halved (approximately 15-20% vs 30-40%)
• Miscarriage rates are increased (approximately 40-50% in some studies vs 15-20% baseline)
• Live birth rates are significantly lower -- some meta-analyses report a 50% reduction in the odds of live birth

This is why all major reproductive medicine societies (ESHRE, ASRM, NICE) recommend treatment of hydrosalpinx before IVF.

4. Impact Even with Unilateral Hydrosalpinx

Even when only one tube has hydrosalpinx, IVF outcomes are reduced. The fluid from the affected side can still leak into the uterus and impair implantation. This is why treatment is recommended for any visible hydrosalpinx before IVF, regardless of whether the condition is unilateral or bilateral.

Because hydrosalpinx is often asymptomatic, diagnosis typically occurs during the investigation of infertility. Several methods are used:

HSG (Hysterosalpingography) -- First-Line Screening

HSG is usually the first test to suggest hydrosalpinx:

1. Contrast dye is injected through the cervix into the uterus
2. X-ray images track the dye as it fills the uterine cavity and enters the fallopian tubes
3. In hydrosalpinx, the dye fills the dilated, distended tube but does not spill from the fimbrial end
4. The characteristic appearance is a sausage-shaped or retort-shaped contrast collection at the distal end of the tube

Strengths: Outpatient procedure, identifies tubal pathology, widely available in India Limitations: Cannot determine the severity of hydrosalpinx, may miss small hydrosalpinges, uncomfortable

Cost in India: Rs 3,000-8,000

Transvaginal Ultrasound

Ultrasound can identify hydrosalpinx, particularly when the tube is significantly distended:

• A tubular, fluid-filled, elongated structure adjacent to the ovary is characteristic
• The "cogwheel sign" (incomplete mucosal folds visible within the tube) is suggestive
• Ultrasound may miss small hydrosalpinges that are not distended enough to be visible
• Sensitivity for hydrosalpinx: approximately 85% for large hydrosalpinges, lower for small ones

Cost in India: Rs 1,500-4,000

Diagnostic Laparoscopy -- The Gold Standard

Laparoscopy provides definitive diagnosis and allows simultaneous treatment:

1. Direct visualisation of the fallopian tubes reveals the distended, fluid-filled tube
2. Chromopertubation (dye test) confirms blockage -- dye enters but does not exit the tube
3. The surgeon can assess the condition of the tubal wall, fimbriae, and surrounding adhesions
4. The extent and severity of the hydrosalpinx can be precisely characterised
5. Salpingectomy or tubal occlusion can be performed in the same procedure

Cost in India: Rs 50,000-1,50,000

Additional Tests

• TB-PCR on endometrial biopsy: Essential in the Indian context to rule out genital tuberculosis as the underlying cause
• Chlamydia antibody test: Indicates past chlamydial infection
• Saline sonohysterogram (SHG): Can sometimes visualise fluid-filled tubes during saline infusion

Standard Diagnostic Tests in India

• HSG — X-ray dye test showing characteristic sausage-shaped dilation and absent contrast spill from the distal tube.
• Transvaginal Ultrasound — Non-invasive imaging showing tubular fluid collection adjacent to the ovary, with or without visible mucosal folds.
• Laparoscopy with Chromopertubation — Definitive surgical diagnosis with direct tube visualisation and dye test. Allows simultaneous treatment.
• TB-PCR / Endometrial Biopsy — Molecular testing for genital tuberculosis — critical in India, where TB causes a substantial proportion of hydrosalpinx cases.
• Chlamydia Antibody Test — Blood test indicating past chlamydial infection, the most common worldwide cause of tubal damage leading to hydrosalpinx.

The treatment of hydrosalpinx before IVF is one of the most strongly evidence-supported recommendations in reproductive medicine. Three main approaches are available:

Option 1: Laparoscopic Salpingectomy (Tube Removal) -- Gold Standard

Salpingectomy -- surgical removal of the affected fallopian tube -- is the most studied and most recommended treatment for hydrosalpinx before IVF.

The Evidence:

The landmark Scandinavian multicentre RCT (Strandell et al., 1999) randomised women with hydrosalpinx to either salpingectomy before IVF or IVF alone. The results were decisive:

• Live birth rate with salpingectomy before IVF: 28.6% vs 16.3% without (p < 0.05)
• Salpingectomy nearly doubled the live birth rate
• No adverse effect on ovarian response to stimulation

Subsequent meta-analyses and systematic reviews have consistently confirmed these findings:

• A Cochrane systematic review (Johnson et al., 2010) concluded that laparoscopic salpingectomy before IVF improves the odds of clinical pregnancy (OR 2.14) and ongoing pregnancy (OR 2.31)
• The 2023 ESHRE guidelines strongly recommend salpingectomy for ultrasound-visible hydrosalpinx before IVF
• ASRM and NICE guidelines concur with this recommendation

Key points about salpingectomy:

• Performed laparoscopically (minimally invasive, 2-3 small incisions)
• Removes only the damaged tube, not the ovary
• Does NOT reduce ovarian reserve: The ovarian blood supply comes from the ovarian artery (a direct branch of the aorta) and is independent of the fallopian tube. Multiple studies confirm that AMH levels and antral follicle counts remain stable after salpingectomy
• Recovery time: 1-2 weeks, with IVF typically starting 1-2 months later
• Can be performed bilaterally if both tubes are affected

Cost in India: Rs 50,000-1,20,000

Option 2: Proximal Tubal Occlusion (Tube Clipping or Blocking)

For women where salpingectomy is technically difficult -- for example, when dense adhesions from TB or endometriosis make tube removal risky -- an alternative is to clip or occlude the tube at its proximal end (where it connects to the uterus). This prevents the hydrosalpinx fluid from draining into the uterine cavity while leaving the tube in place.

Evidence: A Cochrane review and network meta-analysis found that proximal tubal occlusion is comparable to salpingectomy in terms of IVF outcomes. Both interventions eliminate the negative effect of hydrosalpinx fluid on implantation.

When to consider:

• Dense pelvic adhesions making salpingectomy hazardous
• Concerns about compromising ovarian blood supply (rare, but a theoretical risk in difficult surgical cases)
• Patient preference for a less invasive approach

Cost in India: Rs 40,000-80,000

Option 3: Ultrasound-Guided Aspiration

Needle aspiration of the hydrosalpinx fluid under ultrasound guidance, performed either before or at the time of oocyte retrieval.

Advantages: Minimally invasive, no surgery, can be done during egg retrieval Disadvantages:

• Very high recurrence rate (fluid re-accumulates rapidly in most cases)
• Temporary benefit only -- fluid typically returns within days to weeks
• Should be considered a temporising measure, not a definitive treatment
• Some studies show modest short-term benefit, but evidence is weaker than for salpingectomy

When to consider:

• Patient unable or unwilling to undergo surgery
• Need for urgent IVF cycle without time for surgical recovery
• Bridging measure while planning definitive treatment

Cost in India: Rs 10,000-25,000

Which Treatment is Best?

Current evidence supports the following hierarchy:

1. Salpingectomy: First-line recommendation (strongest evidence, most durable benefit)
2. Proximal tubal occlusion: Excellent alternative when salpingectomy is technically difficult
3. Aspiration: Inferior option; consider only when surgery is not feasible

The recommendation to treat hydrosalpinx before IVF is backed by some of the strongest evidence in reproductive medicine. Here is a summary of the landmark studies:

Strandell et al. (1999) -- The Scandinavian Multicentre RCT

• Design: Multicentre randomised controlled trial across Scandinavian IVF centres
• Participants: 204 women with hydrosalpinx scheduled for IVF
• Intervention: Salpingectomy before IVF vs IVF alone
• Primary outcome: Live birth rate 28.6% (salpingectomy) vs 16.3% (control)
• Conclusion: Salpingectomy before IVF significantly improves live birth rates

Cochrane Systematic Review (Johnson et al., 2010)

• Included studies: 3 RCTs with 329 women
• Findings: Salpingectomy before IVF improved odds of ongoing pregnancy (OR 2.31, 95% CI 1.48-3.60) and clinical pregnancy (OR 2.14, 95% CI 1.42-3.21)
• Conclusion: Laparoscopic salpingectomy should be offered to women with hydrosalpinges prior to IVF

Network Meta-Analysis (2025)

• Design: Systematic review and network meta-analysis comparing salpingectomy, proximal occlusion, and aspiration
• Findings: Both salpingectomy and proximal tubal occlusion significantly improved IVF outcomes compared to no treatment. Aspiration showed modest benefit but was inferior to surgical approaches
• Conclusion: Either salpingectomy or proximal occlusion is appropriate; choice depends on clinical circumstances

Guideline Recommendations

IVF Outcomes: With vs Without Hydrosalpinx Treatment

The impact of treating hydrosalpinx before IVF is dramatic:

Rates shown are per embryo transfer for women under 38.

After salpingectomy, IVF success rates return to levels comparable to women with tubal factor infertility without hydrosalpinx -- confirming that the fluid, not the tube itself, was the problem.

IVF Success Rates by Age (After Hydrosalpinx Treatment)

These rates assume hydrosalpinx has been adequately treated before IVF.

India-Specific Considerations

• Indian IVF registries report clinical pregnancy rates of 35-42% per transfer for tubal factor patients under 38 after hydrosalpinx treatment
• TB-related hydrosalpinx may have slightly lower IVF success rates if endometrial damage from TB is also present. Endometrial assessment after ATT completion is essential
• Multi-centre Indian data suggests cumulative live birth rates of 50-65% over 3 IVF cycles for women under 38 with treated hydrosalpinx

Understanding the financial implications helps in planning treatment. Costs vary by city, hospital type (government vs private), and individual circumstances.

Total Treatment Cost Estimate

For a typical treatment pathway (salpingectomy followed by IVF):

• Salpingectomy + 1 IVF cycle: Rs 2,00,000-4,20,000
• Salpingectomy + 2 IVF cycles: Rs 3,50,000-7,20,000
• Salpingectomy + 3 IVF cycles: Rs 5,00,000-10,20,000

Emotional Impact

Being told you need to have your fallopian tube removed before you can even begin IVF can feel emotionally overwhelming. Common reactions include:

• Grief over the loss of natural conception possibility: Especially when both tubes are affected
• Anxiety about surgery and its outcomes: Fear of surgical complications or the finality of tube removal
• Financial stress: The combined cost of surgery and IVF can be substantial
• Frustration with the two-step process: Needing surgery before IVF adds time and emotional burden

Coping Strategies

• Understand the evidence: Knowing that salpingectomy genuinely improves your IVF chances can reframe the surgery as a positive, empowering step
• Seek support: Fertility counsellors and support groups can help process emotions. Several active Indian fertility communities exist on social media
• Focus on the outcome: Salpingectomy is a well-established procedure with a strong evidence base for improving pregnancy rates
• Ask your doctor questions: Understanding your specific situation reduces anxiety and empowers decision-making